Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.21 USD | +3.93% | -2.27% | +12.32% |
13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.32% | 164.62Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+0.79% | 2.23TCr | |
-12.64% | 2.22TCr | |
-4.59% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Soleno Therapeutics Files Mixed Shelf